Lon T. Spada
37Patents
10h-index
35Co-inventors
75Inventor score
Filing activity: Apr 7, 1988 → Nov 11, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8512738B2 | Biodegradable intravitreal tyrosine kinase implants | Human Necessities | 58 | Active |
| US8147865B2 | Steroid-containing sustained release intraocular implants and related methods | Human Necessities | 34 | Active |
| US4908403A | Pressure sensitive adhesives of acetoacetoxy-alkyl acrylate polymers | Emerging Cross-Sectional Technologies | 33 | Expired |
| US5747192A | Single ply PSA labels for battery applications | Electricity | 32 | Expired |
| US7178703B2 | Autoclaveable small-volume dropper bottle | Performing Operations; Transporting | 31 | Expired |
| US6293037A | Pressure-sensitive adhesives and self-adhesive postage stamps made therewith | Emerging Cross-Sectional Technologies | 24 | Expired |
| US5122567A | Pressure sensitive adhesives of acetoacetoxy-alkyl acrylate polymers | Emerging Cross-Sectional Technologies | 19 | Expired |
| US5817426A | Acrylic pressure-sensitive adhesives for low-energy surfaces and corrugated board | Emerging Cross-Sectional Technologies | 14 | Expired |
| US8969415B2 | Intraocular drug delivery systems | Human Necessities | 13 | Active |
| US5053452A | Pressure sensitive adhesives and manufactured articles | Emerging Cross-Sectional Technologies | 10 | Expired |
| US9095506B2 | Biodegradable alpha-2 agonist polymeric implants and therapeutic uses thereof | Human Necessities | 9 | Active |
| US9522113B2 | Biodegradable alpha-2 agonist polymeric implants and therapeutic uses thereof | Human Necessities | 8 | Active |
| US9149428B2 | Processes for making cyclic lipid implants for intraocular use | Human Necessities | 8 | Active |
| US7063241B2 | Dispensing tip | Performing Operations; Transporting | 7 | Expired |
| US8257730B2 | Steroid-containing sustained release intraocular implants and related methods | Human Necessities | 7 | Active |
| US8846073B2 | Low temperature processes for making cyclic lipid implants for intraocular use | Human Necessities | 6 | Active |
| US10441543B2 | Processes for making cyclic lipid implants for intraocular use | Human Necessities | 6 | Active |
| US9327059B2 | Steroid-containing sustained release intraocular implants and related methods | Human Necessities | 5 | Active |
| USD521867S1 | Skirted closure | General | 5 | Expired |
| US8771722B2 | Methods of treating ocular disease using steroid-containing sustained release intraocular implants | Human Necessities | 5 | Active |
| US7749530B2 | Kinase inhibitors | Chemistry; Metallurgy | 4 | Active |
| US9233070B2 | Biodegradable intravitreal tyrosine kinase implants | Human Necessities | 3 | Active |
| US8715713B2 | Solvent cast film sustained release latanoprost implant | Human Necessities | 2 | Active |
| US8455656B2 | Kinase inhibitors | Human Necessities | 2 | Active |
| US8771745B2 | Prostaglandin and prostamide drug delivery systems and intraocular therapeutic uses thereof | Human Necessities | 2 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.